Earnings4886ASKA Pharmaceutical Holdings Co.,Ltd.
ASKA Pharmaceutical Holdings Reports Q1 FY2027 Earnings Presentation: Revenue of 14.5 billion
TOKYO, Aug 04 (Pulse News Wire) – ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T) released its earnings presentation for Q1 FY2027.
Revenue was ¥14.5 billion. Operating profit was ¥710 million. Ordinary profit was ¥820 million.
Total assets stood at ¥110 billion.
Financial results — FY2027/3 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥17,384M | -1.5% |
| Operating profit | ¥711M | -51.4% |
| Net profit | ¥533M | -57.5% |
Next period forecast
Revenue
¥73,000M
+2.6%Op. profit
¥6,200M
+6.3%Net profit
¥4,800M
-11.5%Figures in millions of yen
End of article